Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vanguard Total Bond Market Index Fund ETF (BND) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

Vanguard Total Bond Market Index Fund ETFTrade
Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Vanguard Total Bond Market Index Fund ETF vs Regeneron Pharmaceuticals Inc — how do they compare? Vanguard Total Bond Market Index Fund ETF trades at $72.25, while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Vanguard Total Bond Market Index Fund ETF pays none, and Regeneron Pharmaceuticals Inc is trading nearer its 52-week high, Vanguard Total Bond Market Index Fund ETF nearer its low. Which is the better fit depends on your goals.

BNDREGN
52-Week High
$75.17$812.27
52-Week Low
$72.15$555.51
Market Cap
$82.06B
Sector
Health
Enterprise Value
$76.77B
Dividend Yield
0.47%

Returns comparison

Trailing returns across standard periods

About Vanguard Total Bond Market Index Fund ETF

This index measures the performance of a wide spectrum of public, investment-grade, taxable, fixed income securities in the US, including government, corporate, and international dollar-denominated bonds, as well as mortgage-backed and asset-backed securities-all with maturities of more than 1 year. All of the fund's investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the index.

Read more on BND

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Read more on REGN